Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2010
10/21/2010US20100267059 Immunodeficiency screening at point of care
10/21/2010US20100267058 Circulating ret receptor
10/21/2010US20100267057 Cell Surface Display, Screening and Production of Proteins of Interest
10/21/2010US20100267056 Differential labelling method
10/21/2010US20100267055 One-step immunoassays exhibiting increased sensitivity and specificity
10/21/2010US20100267054 Measuring The Activity Of Proteases
10/21/2010US20100267053 Akt3 polypeptides
10/21/2010US20100267052 Compositions and methods for diagnosis and treatment of type 2 diabetes
10/21/2010US20100267051 Annexin for cancer risk assessment
10/21/2010US20100267050 Methods and compositions for targeting polyubiquitin
10/21/2010US20100267049 Diagnostic devices and related methods
10/21/2010US20100267048 Method for measurement of hemoglobin and hemoglobin derivative, and measurement kit
10/21/2010US20100267047 Test Method on Feline Vaccinated with Feline Immunodeficiency Virus Vaccine, and Antigen for Use in the Test
10/21/2010US20100267046 Isoform-selective inhibitor and activators of pde3 cyclic nucleotide phosphodiesterases
10/21/2010US20100267045 Cudr as biomarker for cancer progression and therapeutic response
10/21/2010US20100267042 Antigen-Presenting Cell Populations And Their Use As Reagents For Enhancing Or Reducing Immune Tolerance
10/21/2010US20100267040 MN/CA IX and Cancer Prognosis
10/21/2010US20100267035 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS
10/21/2010US20100267029 Method of identifying the plant species of the genus uncaria
10/21/2010US20100267027 Her-2 binding antagonists
10/21/2010US20100267022 Monocyte-derived nucleic acids and related compositions and methods
10/21/2010US20100267009 Method for the in vitro diagnosis and/or in vitro therapy monitoring of infections
10/21/2010US20100267008 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
10/21/2010US20100267007 Solid-fluid composition and uses thereof
10/21/2010US20100267005 Crosslinking Within Coordination Complexes
10/21/2010US20100267004 Method, Substances and Kits for Labeling Population of RNA and Other Substances Containing Vicinal Diols
10/21/2010US20100266707 Method of treating cachexia with the removal or inactivation of macrophage inhibitory cytokine-1
10/21/2010US20100266680 Treatment of Cancer Using TLR3 Agonists
10/21/2010US20100266624 Hepatitis-c virus testing
10/21/2010US20100266615 D1-1 nucleic acids, polypeptides and related methods
10/21/2010US20100266610 Auto-antibody markers of autoimmune disease
10/21/2010US20100266604 Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
10/21/2010US20100266603 Monoclonal Antibody Specific to Ochratoxin A
10/21/2010US20100266602 Method for Diagnosing Rheumatoid Arthritis via Assaying Myofibroblast-Like Synoviocytes for Fibroblast Activation Protein
10/21/2010US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
10/21/2010US20100266583 Inhibition of il-17 production
10/21/2010US20100266582 Inhibition of il-17 production
10/21/2010US20100266576 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications
10/21/2010US20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING
10/21/2010US20100266569 Prostatic acid phosphatase for the treatment of pain
10/21/2010US20100266558 Method and assay for glycosylation pattern detection related to cell state of stem cells
10/21/2010US20100266530 FcRN ANTIBODIES AND USES THEREOF
10/21/2010US20100266507 Luminescent compounds
10/21/2010US20100266502 Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
10/21/2010US20100266498 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
10/21/2010US20100266495 Anti-Cancer Activity of an Anti-Thymidine Kinase Monoclonal Antibody
10/21/2010US20100266494 Treatment of cancer with novel anti-il13 monoclonal antibodies
10/21/2010US20100266490 Metalloproteinase Binding Proteins
10/21/2010US20100266452 Measuring chip
10/21/2010US20100266450 Microfluidic device and method of manufacturing the same and sensor incorporating the same
10/21/2010US20100264042 Method of monitoring gas composition
10/21/2010US20100263461 Die-cast article quality judging method, die-casting machine selecting method, and die-casting condition determining method
10/21/2010US20100263434 Gas sensor
10/21/2010DE202008017883U1 Vorrichtung und Anordnung für einen Teststreifenhalter Device and arrangement for a test strip holder
10/21/2010DE102009056284A1 Fruit's ripening condition determining method, involves plunging electrodes into acid contained in fruits, and determining ripening condition of fruits through current or resistance measurement by using multimeter
10/21/2010DE102009017304A1 Vorrichtung und Verfahren zur Messung eines Blutbestandteils im Blut für eine extrakorporale Blutbehandlungsvorrichtung Apparatus and method for measuring a blood component in the blood for an extracorporeal blood treatment device
10/21/2010DE102009016848A1 Gas-Analysegerät mit einer Kombination aus Gasentfeuchter und Gaskonverter Gas analyzer with a combination of gas and Gasentfeuchter Converter
10/21/2010DE102009015188A1 Anlage zur Entnahme von Abgasproben von Verbrennungskraftmaschinen und deren Verwendung Plant for the removal of exhaust sample of internal combustion engines and their use
10/21/2010DE102009014946A1 Tensiometer for measuring water tension in e.g. soils, has water absorptionable measuring medium connected with sensing element of sensor that directly or indirectly detects water content of measuring medium
10/21/2010DE102009013069B4 Verfahren und Vorrichtung zur Beschaffenheitsuntersuchung von säulenförmigen oder zylindrischen Abschnitten von Körpern Method and device for quality testing of columnar or cylindrical sections of bodies
10/21/2010DE102005028896B4 Vorrichtung und Verfahren für eine beschleunigte Oxidationsbestimmung von Kraftstoffen oder Mineralölprodukten sowie ein Computerprogramm zur Steuerung einer solchen Vorrichtung und ein entsprechendes computerlesbares Speichermedium Device and method for the accelerated oxidation test of fuels or petroleum products, and a computer program for controlling such an apparatus and a corresponding computer-readable storage medium
10/21/2010DE102005011739B4 Verfahren zur Bestimmung bzw. Überprüfung der Durchhärtung eines mit Druckfarbe bedruckten Objektes, Prüfvorrichtung, deren Verwendung und Prüfanordnung Method for determining or reviewing the curing of printed with ink object, Tester, their use, and setup
10/21/2010CA2791632A1 Biomarkers
10/21/2010CA2789869A1 Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease
10/21/2010CA2759065A1 On-board control detection
10/21/2010CA2759050A1 Biomarker for monitoring patients
10/21/2010CA2758939A1 Direct fluorescene immunoassay for viral antigens
10/21/2010CA2758933A1 Histone modification patterns for clinical diagnosis and prognosis of cancer
10/21/2010CA2758911A1 Expanding the dynamic range of a test strip
10/21/2010CA2758826A1 Methods and gene expression signature for assessing ras pathway activity
10/21/2010CA2758624A1 Method for determining the cbl-b expression
10/21/2010CA2758585A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease
10/21/2010CA2758546A1 Quality control bioassays for nutriceutical and medicinal products
10/21/2010CA2758531A1 Inflammatory bowel disease prognostics
10/21/2010CA2758526A1 Diagnostic devices and related methods
10/21/2010CA2758520A1 Methods of assessing activity of a polysaccharide composition
10/21/2010CA2758382A1 Ensemble-decision aliquot ranking
10/21/2010CA2758351A1 Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
10/21/2010CA2758229A1 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
10/21/2010CA2757996A1 Method for quantifying modified peptides
10/21/2010CA2757741A1 Detecting phospholipidosis and diagnosing lysosomal storage disorders
10/21/2010CA2757382A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/21/2010CA2757289A1 Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
10/21/2010CA2756685A1 Emulsions of perfluorocarbons
10/21/2010CA2743891A1 Signature of secreted protein isoforms specific to ovarian cancer
10/21/2010CA2669470A1 Assay for detecting cathepsin k activity in bone, cartilage and/or soft tissue
10/20/2010EP2241892A1 Method of detecting leukemic cell
10/20/2010EP2241891A1 An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
10/20/2010EP2241890A2 Method for determining the sensitivity of patients suffering from a cancer disease to biological therapy
10/20/2010EP2241889A1 RBM3 protein in colorectal cancer prognostics
10/20/2010EP2241888A2 Predicting mortality and detecting severe disease
10/20/2010EP2241887A2 Diagnostics, drug screening and treatment for cancer
10/20/2010EP2241886A1 Homogeneous agglutination immunoassay method and kit for such method
10/20/2010EP2241885A1 Agent and method for diagnosis on the occurrence of alzheimer's disease or the tendency to develop alzheimer's disease
10/20/2010EP2241884A2 Selection of anti ageing compounds using mouse cell models with mutations in the DNA repair mechanisms.
10/20/2010EP2241883A2 Method and apparatus for estimating features of target materials by using kinetic change information
10/20/2010EP2241636A1 Gene expression profiling in biopsied tumor tissues
10/20/2010EP2241625A1 Proteinase K resistant surface protein of neisseria meningitidis
10/20/2010EP2241623A2 Monoclonal antibody against a human cytokine receptor
10/20/2010EP2241622A2 Human trk receptors and their derivatives
1 ... 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 ... 3937